Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

How payment scheme affects patients' adherence to medications? A systematic review.

Aziz H, Hatah E, Makmor Bakry M, Islahudin F.

Patient Prefer Adherence. 2016 May 13;10:837-50. doi: 10.2147/PPA.S103057. eCollection 2016. Review.

2.

Evolving Patient Compliance Trends: Integrating Clinical, Insurance, and Extrapolated Socioeconomic Data.

Klobusicky JJ, Aryasomayajula A, Marko N.

AMIA Annu Symp Proc. 2015 Nov 5;2015:766-74. eCollection 2015.

3.

International experience in controlling pharmaceutical expenditure: influencing patients and providers and regulating industry - a systematic review.

Lee IH, Bloor K, Hewitt C, Maynard A.

J Health Serv Res Policy. 2015 Jan;20(1):52-9. doi: 10.1177/1355819614545675. Epub 2014 Aug 4. Review.

4.

Predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries.

Romanelli RJ, Segal JB.

J Gen Intern Med. 2014 Oct;29(10):1372-8. doi: 10.1007/s11606-014-2933-7. Epub 2014 Jun 24.

5.

Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes.

Davidoff A, Lopert R, Stuart B, Shaffer T, Lloyd JT, Shoemaker JS.

Value Health. 2012 May;15(3):404-11. doi: 10.1016/j.jval.2012.01.008. Epub 2012 Apr 10.

6.

Adherence and occurrence of fractures after switching to once-monthly oral bisphophonates.

Briesacher BA, Andrade SE, Harrold LR, Fouayzi H, Yood RA.

Pharmacoepidemiol Drug Saf. 2010 Dec;19(12):1233-40. doi: 10.1002/pds.2048. Epub 2010 Oct 28.

7.

Understanding patient perspectives on communication about the cost of cancer care: a review of the literature.

Hofstatter EW.

J Oncol Pract. 2010 Jul;6(4):188-92. doi: 10.1200/JOP.777002. Epub 2010 Jun 22.

8.

Patients' perspectives on nonadherence to statin therapy: a focus-group study.

Fung V, Sinclair F, Wang H, Dailey D, Hsu J, Shaber R.

Perm J. 2010 Spring;14(1):4-10.

9.

Primary non-adherence of medications: lifting the veil on prescription-filling behaviors.

Solomon MD, Majumdar SR.

J Gen Intern Med. 2010 Apr;25(4):280-1. doi: 10.1007/s11606-010-1286-0. No abstract available.

10.

Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?

Chapman RH, Pelletier EM, Smith PJ, Roberts CS.

Patient Prefer Adherence. 2009 Nov 3;3:265-75.

11.

Cost sharing and the initiation of drug therapy for the chronically ill.

Solomon MD, Goldman DP, Joyce GF, Escarce JJ.

Arch Intern Med. 2009 Apr 27;169(8):740-8; discussion 748-9. doi: 10.1001/archinternmed.2009.62.

12.

Systematic review on quality control for drug management programs: is quality reported in the literature?

Holtorf AP, McAdam-Marx C, Schaaf D, Eng B, Oderda G.

BMC Health Serv Res. 2009 Feb 25;9:38. doi: 10.1186/1472-6963-9-38. Review.

13.

Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis.

Curtis JR, Xi J, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E.

Med Care. 2009 Mar;47(3):334-41. doi: 10.1097/MLR.0b013e31818afa1c.

14.

Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions.

Das-Douglas M, Riley ED, Ragland K, Guzman D, Clark R, Kushel MB, Bangsberg DR.

AIDS Behav. 2009 Feb;13(1):1-9. doi: 10.1007/s10461-008-9401-5. Epub 2008 May 16.

15.

What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Gemmill MC, Thomson S, Mossialos E.

Int J Equity Health. 2008 May 2;7:12. doi: 10.1186/1475-9276-7-12.

16.

Effects of increased patient cost sharing on socioeconomic disparities in health care.

Chernew M, Gibson TB, Yu-Isenberg K, Sokol MC, Rosen AB, Fendrick AM.

J Gen Intern Med. 2008 Aug;23(8):1131-6. doi: 10.1007/s11606-008-0614-0. Epub 2008 Apr 29.

17.

Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.

Gilman BH, Kautter J.

Health Serv Res. 2008 Apr;43(2):478-95. doi: 10.1111/j.1475-6773.2007.00774.x.

18.

Psychiatric epidemiology: challenges and opportunities.

Kessler RC.

Int Rev Psychiatry. 2007 Oct;19(5):509-21. Review.

19.

Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study.

Gellad WF, Haas JS, Safran DG.

J Gen Intern Med. 2007 Nov;22(11):1572-8. Epub 2007 Sep 20.

Supplemental Content

Support Center